4-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid, 95.0%, 250mg

Methyl 2-amino-3-fluorobenzoate, 95.0%, 1g

1-[6-(Trifluoromethyl)pyridin-3-yl]ethanone, 97.0%, 1g

4-(6-Nitropyridin-3-yl)morpholine, 95.0%, 5g

3-Amino-3-(4-bromophenyl)acrylonitrile, 97.0%, 5g

[(5-cyclopentyl-1,2,4-oxadiazol-3-yl)methyl]amine hydrochloride, 95.0%, 1g

ethyl 5-amino-1-(4-methoxybenzyl)-1H-pyrazole-4-carboxylate, 95.0%, 250mg

1,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinecarboxylic acid, 95.0%, 5g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 0.10 µm, 1 Piece(s)

2-Bromo-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbaldehyde, 98%, 100mg

7-Chloro-2,4-dimethyl-[1,8]naphthyridine, 95.0%, 1g

2-Bromo-4-formylnicotinonitrile, 97%, 1g

Methyl 2,5-dioxo-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 1g